Cargando…
Inhaled seralutinib exhibits potent efficacy in models of pulmonary arterial hypertension
BACKGROUND: Signalling through platelet-derived growth factor receptor (PDGFR), colony-stimulating factor 1 receptor (CSF1R) and mast/stem cell growth factor receptor kit (c-KIT) plays a critical role in pulmonary arterial hypertension (PAH). We examined the preclinical efficacy of inhaled seralutin...
Autores principales: | Galkin, Anna, Sitapara, Ravikumar, Clemons, Bryan, Garcia, Eduardo, Kennedy, Michael, Guimond, David, Carter, Laura L., Douthitt, Ashley, Osterhout, Robin, Gandjeva, Aneta, Slee, Deborah, Salter-Cid, Luisa, Tuder, Rubin M., Zisman, Lawrence S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724289/ https://www.ncbi.nlm.nih.gov/pubmed/35680144 http://dx.doi.org/10.1183/13993003.02356-2021 |
Ejemplares similares
-
Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension
por: Pullamsetti, Soni Savai, et al.
Publicado: (2023) -
Phosphoproteomic analysis of lung tissue from patients with pulmonary
arterial hypertension
por: Sitapara, Ravikumar, et al.
Publicado: (2021) -
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension
por: Frantz, Robert P., et al.
Publicado: (2021) -
SU5416 plus hypoxia but not selective VEGFR2 inhibition with cabozantinib plus hypoxia induces pulmonary hypertension in rats: potential role of BMPR2 signaling
por: Sitapara, Ravikumar, et al.
Publicado: (2021) -
Partial Netrin-1 Deficiency Aggravates Acute Kidney Injury
por: Grenz, Almut, et al.
Publicado: (2011)